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Abstract
Introduction The aim of this retrospective study was to
evaluate the clinical outcome of patients with spinal dural
arteriovenous fistulas (SDAVFs) that were treated with
surgery, catheter embolization, or surgery after incomplete
embolization.
Methods The study included 21 consecutive patients with
SDAVFs of the thoracic, lumbar, or sacral spine who were
treated in our institution from 1994 to 2007. Thirteen
patients were treated with catheter embolization alone. Four
patients underwent hemilaminectomy and intradural inter-
ruption of the fistula. Four patients were treated by
endovascular techniques followed by surgery. The clinical
outcome was assessed using the modified Aminoff–Logue
scale (ALS) for myelopathy and the modified Rankin scale
(MRS) for general quality of life. Patient age ranged from
44 to 77 years (mean 64.7 years).
Results Surgical as well as endovascular treatment resulted
in a significant improvement in ALS (−62.5% and −31.4%,
respectively, p<0.05) and a tendency toward improved
MRS (−50% and −32%, respectively) scores. Patients that
underwent surgery after endovascular treatment due to
incomplete occlusion of the fistula showed only a tendency
for improvement in the ALS score (−16.7%), whereas the
MRS score was not affected.
Conclusion We conclude that both endovascular and
surgical treatment of SDAVFs resulted in a good and
lasting clinical outcome in the majority of cases. In specific
situations, when a secondary neurosurgical approach was
required after endovascular treatment to achieve complete
occlusion of the SDAVF, the clinical outcome was rather
poor. The best first line treatment modality for each
individual patient should be determined by an interdisci-
plinary team.
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Introduction
Spinal dural arteriovenous fistulas (SDAVFs) are rare
pathological entities consisting of an arteriovenous shunt
between one ore more branches of a dural artery and the
medullary venous system. The fistula is usually located in
the dura of the nerve root and/or adjacent spinal dura and
fed by a dural branch of the corresponding segmental
radicular artery. The drainage is accomplished by a
medullary vein, which leads to retrograde filling of the
coronal vein plexus, resulting in its congestion and
dilatation. The venous hypertension with a reduced pressure
gradient finally causes reduced perfusion, ischemia, and
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edema of the spinal cord, typically leading to a slowly
progressive congestive myelopathy [1, 2]. Clinically, the
disease usually presents with progressive gait disturbance
as well as numbness and paresthesia of the lower
extremities [3]. However, radiculopathy and rarely sub-
arachnoid hemorrhage have also been reported to occur in
the context of SDAVFs [4, 5]. The frequently observed
discrepancy between the location of the SDAVF and the
spinal level responsible for clinical symptoms suggests that
the symptoms might be primarily depend on the venous
drainage [6, 7].
SDAVFs account for about 70% of spinal arteriovenous
malformations (AVM), with an annual incidence of five to
ten cases per million [8]. There is a strong gender
predisposition in males (about 80%) with an average age
of 62 years at onset of clinical symptoms [9]. The
pathogenesis of SDAVFs remains unclear. The middle-age
onset suggests an acquired condition, unlike intradural
arteriovenous fistulas or intramedullary AVM, which are
considered to represent congenital malformations [10, 11].
In contrary to intracranial dural arteriovenous fistulas,
SDAVFs are not associated with thrombophilia [12].
Metachronous double SDAVFs can be a rare problem in
the management of the disease [13].
Due to the low incidence and the nonspecific symptom-
atology, an appropriate diagnostic workup is often not
performed, and the time to diagnosis is long. In a large
series of 66 patients, the average time from symptoms onset
to diagnosis was reported to be 27 months [9]. Late
diagnosis is problematic, as the condition can be treated
and recovery after surgical and/or endovascular treatment is
good [3].
Magnetic resonance (MR) imaging of the whole spine is
the screening procedure of choice and has replaced
myelography. Typical MR findings include spinal cord
signal hyperintensity in T2-weighted images, enlargement
of the spinal cord, and dilatation of the perimedullary veins.
Radiological findings frequently disappear after treatment
and are often correlated with clinical symptoms [14]. A
recent report suggested that diffusion-weighted imaging
and apparent diffusion coefficient maps might be useful to
identify the vasogenic edema caused by SDAVFs [15].
Contrast-enhanced MR angiography [16–18] and multi-
slice computerized tomographic (CT) angiography [19]
may facilitate the diagnostic procedure. However, if an
SDAVF is suspected, a selective multilevel spinal catheter
angiography is required to confirm the diagnosis and
determine the exact feeder location and vascular anatomy
of the fistula.
Due to the low incidence of the disease, only limited
data on the management of these patients are available.
Treatment options for SDVAF include endovascular and
microsurgical occlusion of the fistula. The surgical treat-
ment consists of intradural interruption of the draining vein
at the fistula point [20]. Alternatively, endovascular
treatment with selective catheter embolization is possible
[21]. Endovascular therapy as opposed to open surgery is a
less invasive treatment choice and can usually be performed
in the same session as diagnostic angiography. Whether or
not these advantages are counterbalanced by a lower
recanalization rate and therefore a better long-term outcome
after surgical treatment remains a matter of debate.
Although several studies have reported good and lasting
results for both therapeutic strategies, a meta-analysis based
on the data from 16 surgical and ten endovascular studies
favored surgical treatment [22]. However, the decision
between endovascular and surgical treatment remains a
controversially discussed topic in the current literature [23],
and further investigations are necessary to clarify this issue.
The present study assessed the clinical outcome of 21
patients with SDAVFs treated at our institution with
surgery, catheter embolization or surgery after embolization
during the last 12 years.
Materials and methods
The series consisted of 21 patients with dural fistulas of the
thoracic, lumbar, or sacral spine that were treated in our
institution, which is a large third-level neurovascular center
in Switzerland, from 1994 to 2007. Patient age ranged from
44 to 77 years (mean 64.7 years) and included five female
(24%) and 16 male (76%) subjects. All patients underwent
diagnostic workup with MR imaging of the whole spinal
cord for screening and consecutive selective spinal angiog-
raphy, which confirmed the presence of an SDAVF in all
cases. Diagnostic and interventional angiography was per-
formed on a biplane digital subtraction angiography unit
(CAS 500; Toshiba Medical Systems, Tokyo, Japan).
Patients underwent diagnostic angiography and emboli-
zation under local anesthesia using the transfemoral
approach. Depending on the origin of the feeding arteries,
various pre-shaped catheters with an inner diameter of 0.97
mm were used for spinal angiography (Spinal Super
Torque, Johnson & Johnson, Division Cordis, Switzerland).
Before the diagnostic or interventional procedure, the
diameter of the aorta was measured, based on the MR or
CT image. Depending on the aortic diameter, one of three
different catheter sizes (Berner Spinalkatheter I–III: 10, 13,
or 16 mm) was chosen to get optimal stability during the
intervention [24]. The angiographic protocol included
catheterization of the vertebral and segmental arteries,
including the lower lumbar arteries, median and lateral
sacral arteries, and internal iliac arteries for lower lumbar or
sacral lesions. Selective angiography of the suspected
feeding arteries was then performed. For embolization, a
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1:5 mixture of n-butylcyanoacrylate (Histoacryl, B. Braun
Melsungen AG, Melsungen, Germany) and iodized oil
(Lipiodol Ultra-Fluid, Guerbet, Aulnay-sous-Bois, France)
with added tantalum powder was injected via a micro-
catheter (Fast Tracker 10, Target Therapeutics, Fremont,
CA, USA) coaxially inserted through the guiding catheter
(Fig. 1).
A decision to treat was made in all patients with
angiographically confirmed diagnosis of SDAVF. In the
same angiographic session, an attempt to embolization was
made in all patients where the lesion seemed favorable for
endovascular treatment with a reasonable risk (n=17).
Exclusion criteria included severe arteriosclerosis, arterial
feeders too small to catheterize, and common origin of the
great radicular artery of Adamkiewicz from the same
segmental artery as the feeding artery of the fistula [25].
In these cases (n=4), the decision for surgical treatment was
made after diagnostic angiography. These patients under-
went hemilaminectomy and microsurgical intradural inter-
ruption of the draining vein by clipping and/or coagulation
under general anesthesia (Fig. 2). In a small number of
selected cases (n=3), endovascular treatment was repeated
one time due to partial fistula occlusion after the first
session and configuration of the fistulas that favored
endovascular treatment. Clinical symptoms were assessed
before and after treatment using the modified Aminoff–
Logue grading scale (ALS) for myelopathy (Table 1) [26]
and the modified Rankin scale (MRS) [27]. Patients
underwent clinical examination at 1, 3, 6, and 12 months
after treatment and every 6 months thereafter. Spinal MR
imaging was carried out at 1 month after treatment. Prompt
angiographic reevaluation was performed in patients with-
out clinical improvement after treatment or in case of
secondary deterioration. Follow-ups were available with a
median of 26 months (range 12 to 42 months) after
treatment. All statistical analyses were carried out using a
commercially available software package (GraphPad Instat
3.0, GraphPad Software, San Diego, CA, USA). The
patient groups were compared using the nonparametric
Kruskal–Wallis test followed by Dunn's multiple compar-
isons post hoc analysis. The statistical significance level
was set at p<0.05. Values are presented as mean±SEM.
Fig. 1 Endovascular treatment of a dural arteriovenous fistula with a
feeder on level D6 (patient #18). Preinterventional T2-weighted
sagittal (a) and axial (b) MR sequences showed a prominent medullar
edema (arrows) on the level of D8 to D11 and dilated vascular
structures presenting with flow void (arrowheads) in the perimedullar
intradural space. Spinal angiography with selective catheterization of
the left segmental artery D6 revealed a dural arteriovenous fistula on
this level with rostral drainage (c). After embolization using a
histoacryl/lipiodol mixture with added tantalum powder, no residual
perfusion of the fistula could be demonstrated anymore (arrows, d).
The post-interventional CT scan confirmed the obliteration of the
pathological feeding vessels in the left neuroforamen D6/7 (asterisk)
and the perimedullar draining veins (arrows) by tantalum-containing
embolization material (e, f). The dashed line on sagittal images
indicates the level of axial sections
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Results
A total of 21 consecutive patients (five women and 16 men)
that underwent surgery and/or endovascular treatment of
SDAVFs in our institution between 1995 and 2007 were
retrospectively included in the study (Table 2). All patients
with the exception of one subject suffering from lumbar
back pain as the sole symptom presented with clinical signs
of myelopathy with different grades. The mean ALS score
at admission was 4.9±0.5, whereas the mean MRS score
was 2.9±0.3. None of the patients presented with signs of
hemorrhage, which is consistent with the low incidence of
bleeding from SDAVFs reported in the literature [5, 28]. All
patients underwent selective spinal angiography, which
confirmed an SDAVF of the thoracic (n=11), lumbar (n=
7), or sacral (n=3) spine. In accordance with other studies,
the majority of the SDAVFs in our series were located in
the lower thoracic or lumbar region [29], and the well-
documented strong male preponderance was also observed
in our patient collective [18].
Patients treated by surgery alone showed a significant
improvement in the ALS (4.8±0.8 before and 1.8±0.3 after
treatment, respectively, p<0.05) and a tendency for im-
provement in the MRS (3.0±0.7 before and 1.5±0.3 after
treatment, respectively, p=0.11) scores. Patients treated by
embolization alone also showed significantly improved
ALS (5.1±0.7 before and 3.5±0.5 after treatment, respec-
tively, p<0.05) and a tendency for lower MRS (3.15±0.4
before and 2.15±0.3 after treatment, respectively, p=0.08)
scores. Patients that underwent surgical and endovascular
treatment due to incomplete occlusion of the fistula after
embolization showed only a trend toward improvement in
the ALS score (4.8±1.4 before and 4.0±1.7 after treatment,
respectively), whereas the MRS values were not changed
(2.25±0.3 before and 2.25±0.8 after treatment, respective-
ly). The results expressed as percentages of the pre-
interventional values are presented in Fig. 3.
In four out of 17 cases that were primarily selected for
endovascular treatment in this study, the SDAVF could not
definitely be occluded by this technique, representing a
failure rate of 23.5%.
There were no significant differences in the patient age and
in the pre-interventional ALS and MRS score values between
the surgical, endovascular, and surgical/endovascular treat-
ment groups.
Discussion
Due to the unspecific presentation of initial symptoms in
combination with a usually slow progression of the rare
disease, the diagnosis of an SDAVF remains difficult based
on clinical suspicion. With an annual incidence of five to
ten per million in the Western population [30], the
estimated number of newly developing cases in Switzerland
each year is about 35–70 cases. Due to the coverage of
about 20% of the neurovascular cases in Switzerland by our
institution, it can be estimated that 7–14 patients with
SDAVFs should be admitted per year. The number of 21
patients treated at our institution during the last 12 years
suggests a significant underdiagnosis and undertreatment of
patients with SDAVFs. This notion is particularly of
Table 1 Modified ALS for the assessment of myelopathy
Modified ALS
Gait
0 Normal
1 Leg weakness, abnormal gait or stance,
but no restriction of activity
2 Restricted activity
3 Requiring one stick for walking
4 Requiring two sticks, crutches, or walker
5 Confined to wheelchair
Micturation
0 Normal
1 Hesitancy, frequency, urgency
2 Occasional urinary incontinence or retention
3 Total incontinence or persistent retention
Fig. 2 Surgical technique of occlusion of a dural arteriovenous fistula
(patient #11). After a right hemilaminectomy of D7–8 and exposure of
the dural sac, the dura is microsurgically opened with a linear
paramedian incision (a). Pathologic tortuous draining vessels of the
fistula are exposed, and the fistula point is identified at the level of D7
as the feeding artery enters the intradural space (b, arrow). At this
point, the draining vessel is closed by application of two clips and
bipolar coagulation (c). Successful occlusion of the fistula results in
immediate darkening of the blood in the draining vein
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importance, as 50% of untreated patients become disabled
within 3 years [26, 31, 32]. Nevertheless, the number in the
present study is consistent with those from other reports in
countries with comparable healthcare systems [8, 33, 34].
Hence, we suggest that, even if the symptoms are
unspecific, the threshold for performing diagnostic workup
in case of suspicion of an SDAVF should be lower than
practiced today.
As reported in the literature, treatment by permanent
occlusion of SDAVFs results in clinical improvement in
Fig. 3 Clinical outcome of surgical, endovascular and surgical after
endovascular treatment of SDAVFs. The severity of myelopathic
symptoms was graded using the modified Aminoff–Logue scale (ALS,
a), whereas general quality of life was assessed using the modified
Rankin scale (MRS, b). Surgical and endovascular treatment both
resulted in significantly improved ALS and a tendency for improved
MRS scores, whereas patients treated with surgery after primary
embolization (both) showed no significant clinical improvement in the
ALS and MRS scores. Data are expressed as percentage of
pretreatment values and given as mean±SEM. Asterisk indicates
significant differences (p<0.05) vs. pretreatment values
Table 2 List of patients
Pat # Age Sex Location Side Drainage Treatment Symptoms ALS
pre
ALS
post
MRS
pre
MRS
post
1 67 M D6 Left Caudal Surgical Paraparesis, paresthesia,
anuresis
6 2 5 2
2 67 M D6 Right Caudal+rostral Endovascular (2x) Spastic paraparesis 2 3 2 3
3 57 M D5 Right Caudal Both Spastic paraparesis, ataxia 3 1 2 1
4 68 M L1 Left Rostral Endovascular Severe paraparesis, paresthesia,
incontinence
6 4 5 4
5 59 M D6 Left Caudal Surgical Atactic gait disorder, incontinence 3 1 2 1
6 76 F L2 Right Caudal Endovascular Spastic paraparesis, paresthesia,
incontinence
6 4 3 2
7 57 F L1 Right Caudal Both Paresthesia 2 1 2 1
8 56 M S2 Both Rostral Endovascular Severe paraparesis, incontinence 7 7 4 4
9 74 M D7 Left Caudal Both Paraparesis, paresthesia 6 7 2 3
10 45 M D8 Left Caudal Endovascular Spastic paraparesis, ataxia 3 2 1 1
11 76 M D7 Right Caudal Surgical Spastic paraparesis, paresthesia,
incontinence
6 2 2 1
12 75 M D8 Right Caudal Endovascular Severe paraparesis, anuresis 7 5 4 3
13 52 F S2 Right Rostral Endovascular Low back pain 2 2 2 2
14 75 M D7 Right Rostral Surgical Paraparesis, incontinence 4 2 3 2
15 77 M D6 Left Caudal Endovascular Atactic gait disorder,
paresthesia, pain
3 2 2 1
16 70 M L1 Left Rostral Both Severe paraparesis, incontinence 8 7 3 4
17 63 M L3 Right Rostral Endovascular (2x) Severe paraparesis, cauda lesion 8 6 4 3
18 44 M D6 Left Rostral Endovascular Spastic paraparesis, ataxia,
incontinence
4 2 3 1
19 73 F L3 Right Caudal Endovascular Severe paraparesis, cauda syndrome,
anuresis
8 2 5 1
20 61 M S2 Right Rostral Endovascular (2x) Atactic gait disorder, paresthesia,
incontinence
2 1 1 1
21 67 F L3 Left Rostral Endovascular Severe paraparesis, anuresis 8 6 5 2
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70% of cases [8]. The success of treatment depends on
definitive interruption of the draining vein and not the
arterial feeders, because otherwise the fistula has the
tendency to re-establish flow by recruiting new arterial
feeding vessels, resulting in clinical recurrence [35].
However, there exists some controversy on the choice of
treatment modalities for SDAVFs. Some authors favor
surgical treatment [36–39], whereas others recommend
endovascular embolization [21, 40, 41]. A meta-analysis
of 16 surgical studies by Steinmetz et al. [22] has
demonstrated successful occlusion of the SDAVF in 98%
of the cases with a morbidity of less than 2% and no
mortality. Clinical improvement was found in 55% and
stabilization of the clinical condition in 34% of the
surgically treated patients, respectively. Data from the same
meta-analysis on ten endovascular therapy studies showed
that embolization resulted in initial occlusion of the fistula
in 46% of cases with a morbidity of less than 4% and an
absence of mortality. Due to the heterogeneity and
insufficient longitudinal data of endovascular studies, a
comparison between the clinical efficacy of surgery and
catheter embolization by meta-analysis was not possible. In
a single center series, neurological improvement in patients
treated with embolization alone was reported in 44% and
stabilization of the clinical condition in 56% [42]. Due to
the superior results using surgery as compared to emboli-
zation, Steinmetz and collaborators recommended surgical
treatment as the first-line therapy in dealing with SDAVFs.
On the other hand, experience and techniques in
interventional neuroradiology have constantly evolved
during the last decade, and a more recent report has shown
permanent occlusion of the fistula and a corresponding
improvement of neurological deficits in 81% of endovasc-
ularly treated patients [43]. Another study reported a low
recurrence rate of 10.5% after embolization of SDAVFs and
significant improvements in ALS and Karnofsky perfor-
mance status scores after a mean clinical follow-up period
of more than 100 months [23]. Based on their experience
with endovascular treatment, two other groups advocate an
attempt at embolization after diagnostic angiography and
recommend surgery if endovascular treatment fails [44, 45].
Surgery should be considered in cases in which selective
introduction of the microcatheter is difficult, Adamkiewicz's
artery or the anterior spinal artery originates from the feeding
radicular artery, multiple small feeding arteries are present,
recurrence occurred after embolization, or a previous
embolization attempt was incomplete [46]. In our series,
the decision for surgical treatment was made according to
these criteria with the exception of three cases in which a
second attempt at endovascular treatment was made after
initial incomplete embolization or recurrence because of
angiographic findings very favorable for re-embolization. All
patients that underwent a primary surgical intervention
showed robust recovery of neurological symptoms, and the
complication rate was zero. These results are in line with
another series of 21 patients, where Huffmann et al. [36]
reported complete occlusion of the lesions in all patients and
only a minor complication rate with each one case of
transient neurological deterioration, local cerebrospinal fluid
accumulation, and wound healing problems.
Endovascular treatment has the advantage of minor
invasiveness and can be performed in a single setting after
diagnostic angiography, but occlusion rates are still lower than
in surgical treatment [8]. Due to the lower recanalization rate,
liquid embolic agents, such as cyanoacrylates, are preferred
to polyvinyl alcohol particles for embolization [8, 47]. In
contrast to particles, liquid glue may reach the nidus of the
dural fistula and can penetrate into the venous side, leading
to occlusion of the fistula [48]. If a tantalum-containing
embolization mixture is used, a spinal CT scan can be
performed to document the correct intradural localization of
the embolization material immediately after the intervention
(Fig. 2e–f), which has been previously reported to correlate
with the absence of fistula recanalization and with clinical
improvement [43, 49]. In addition, the tantalum particles
may be helpful for intra-operative radiographic localization
of the SDAVF if there is need for surgical treatment later
[50]. After endovascular treatment, short-term clinical
control examinations are necessary to exclude recurrence of
the fistula due to collaterally reestablished flow in a possibly
non-occluded spinal cord vein. If an angiographic follow-up
is not performed on a regular basis, prompt angiographic
reevaluation is mandatory in case of poor clinical recovery or
secondary deterioration to prevent delayed treatment with
possibly progressive disease [25].
The reasons for the poor outcome in the four patients
that required secondary surgical treatment after endovas-
cular therapy failed are not clear. In three cases, the fistula
could not be completely occluded by endovascular treat-
ment due to the configuration of the fistula (patients #7 and
#16) and due to vasospasm (patient #9). These patients
were immediately scheduled for surgical treatment within
the next weeks. One case (#3) with complete radiological
occlusion of the SDAVF and a favorable initial outcome
after embolization showed clinical deterioration within 3
months and underwent surgical interruption of the fistula a
few weeks later. As all patients presented with a history of
myelopathic symptoms for several months, we do not think
that the additional delay due to the endovascular treatment
attempt is responsible for the poor outcome in this group.
However, although there have been no significant differ-
ences in the severity of the initial clinical presentation
between the different treatment groups, it is possible that
patients with more extensive fistulas have been refractory to
complete occlusion by embolization and subsequently
required surgery, resulting in an inferior outcome in this
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group. Thus, a patient (#9) with an extensive SDAVF that
already presented with severe symptoms and was operated
two times after embolization due to recurrence of the fistula
showed neurological deterioration after treatment.
Our results are in accordance with the data from the
majority of previously reported studies, indicating that
surgical treatment results in a more favorable outcome.
There is still a considerable failure rate of 23.5% for the
group of patients who were primarily selected for endovas-
cular treatment. However, even if the morbidity of surgery is
low, it represents a more invasive procedure than endovas-
cular treatment. As the diagnosis of SDAVF is made at an
average age of 62 years [9], unfavorable preoperative
conditions in elderly and multimorbid patients are common
and have to be taken into account in the decision-making
process. Given that a selective spinal angiography has to be
performed for diagnostic reasons in either case and the
interventional morbidity is low in experienced hands [51],
we recommend attempting endovascular occlusion of the
SDAVF during the same session if the lesion seems
amenable with a reasonable success rate and a low risk of
complications. Thereby, the best modality of treatment has to
be determined on patient-by-patient basis and should be
approached by an interdisciplinary team.
Conclusions
Both endovascular and surgical treatment of SDAVFs resulted
in a significant long-term recovery from myelopathic symp-
toms and in an improvement in general quality of life in the
majority of the treated patients. In cases when endovascular
treatment failed and a secondary neurosurgical approach was
required to achieve complete occlusion of the SDAVF, the
clinical outcome was rather poor. In our opinion, the optimal
first-line treatment strategy for each individual patient should
be determined by an experienced interdisciplinary team.
In addition, it has to be emphasized that the recovery of
clinical symptoms was incomplete in many patients because
the diagnosis was established too late and the patients
already presented with severe and long-lasting neurological
deficits. The diagnostic difficulty remains a main problem
in the management of this rare disease.
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